This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rochester Medical's CEO Discusses F4Q 2011 Results - Earnings Call Transcript

Rochester Medical Corporation ( ROCM)

F4Q 2011 Earnings Call

November 3, 2011 4:30 PM ET

Executives

Jim Conway – Chairman, CEO and President

David Jonas – CFO, Treasurer and Secretary

Analysts

Shaun Vincent [ph] – Feltl & Company

Tyson Bauer – Wealth Monitors

Larry Haimovitch – HMTC

Presentation

Operator

Good day ladies and gentlemen and welcome to the fourth quarter 2011 Rochester Medical Corp earnings conference call. My name is Ryan and I will be your operator for today’s event. At this time all attendee lines are muted in a listen-only mode. And we will be facilitating a question and answer session at the end of today’s call. Additional instructions will be provided at that time. (Operator’s Instructions) As a reminder this call is being recorded for replay purposes.

And I would now like to turn the call over to Mr. Anthony J. Conway, President and CEO. Please proceed sir.

Jim Conway

Thank you and thank you for joining Rochester Medical’s fourth quarter conference call. I am Jim Conway, the Company’s President and CEO. And with me is David Jonas, Rochester Medical’s Chief Financial Officer.

First, I will provide a brief high level review of our fourth quarter. Dave will then provide you with more details on our financial results and then I will give a quick update on a few items and summarize. And then we will take your questions.

Now before starting let me remind you that we will be making some forward-looking statements today and I would refer you to the Safe Harbor statement found in today’s press release and also to the risk factors section in the Company’s Annual Report on Form 10-K for the year ended September 30, 2010. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs